AJAbhishek Joshi

Abhishek Joshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abhishek Joshi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Juhi Raut

    Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra

    4 shared publications
  • Abhay Mudey

    Department of Community Medicine, Datta Meghe Institute of Medical Sciences, Deemed to be University), Sawangi (Meghe), Maharashtra, India

    1 shared publication
  • Abhay Mudey

    Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra

    1 shared publication
  • Anuttam Arijit Pani

    Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha-442001, Maharashtra, India

    1 shared publication
  • Ashok M. Mehendale

    Preventive and Social Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND

    1 shared publication
  • Divya Panicker

    Community Medicine, Datta Meghe Institute of Higher Education and Research Deemed to be University, Wardha, Maharashtra, India

    1 shared publication

Latest Publications

  • Open Access

    Association of caregiver’s burden and mental health status in caregivers of patients with cancer from central rural India: a mixed-method study protocol

    by Divya Panicker, Abhishek Upendra Joshi, Ansar Ahamed V P, Juhi Mangesh Raut

    Introduction: Cancer remains a growing public health challenge in India, impacting not only patients but also their caregivers, often family members who bear the emotional, physical and financial burdens of care. These family caregivers face overwhelming stress, anxiety and depression, particularly in rural areas with limited healthcare access. Cultural expectations often lead them to neglect their own well-being. Many are forced to reduce work or quit jobs, worsening financial strain. Despite their vital role, caregivers are largely overlooked in cancer care discourse. There is an urgent need for India-specific, empathetic research and policies that support caregiver health and recognise caregiving as a public health priority. Methods and analysis: This study employs a sequential explanatory mixed-methods design to examine the association between caregiver burden and mental health status among informal caregivers of patients with cancer in central rural India. In the quantitative phase, a cross-sectional survey will be conducted using systematic random sampling. Data will be collected via a semistructured questionnaire and standardised tools: the Copenhagen Burnout Inventory to assess burnout levels, and the Depression, Anxiety and Stress Scale-21 to evaluate psychological distress. Statistical analysis will include descriptive statistics and regression analysis. The qualitative phase will involve in-depth interviews with purposively selected caregivers to explore lived experiences, coping mechanisms and emotional challenges. Interviews will be transcribed and analysed using thematic content analysis. Integration of quantitative and qualitative findings will provide a comprehensive understanding of caregiver burden and mental health, reflecting both measurable patterns and the human experience of caregiving in a rural setting. Ethics and dissemination: Ethical clearance for this study protocol was obtained from the Institutional Ethics Committee of Datta Meghe Institute of Medical Education and Research, Sawangi (Meghe), Wardha (Approval No. DMIHER(DU)/IEC/2025/436). Permission for data collection was further granted by both the institutional ethics committee and Acharya Vinoba Bhave Rural Hospital, Sawangi (Meghe), Wardha. The findings of this research will be disseminated through publications in peer-reviewed scientific journals and by engaging relevant stakeholders through appropriate channels of communication. Trial registration number: CTRI/2025/08/093357.


  • Open Access

    Towards Healthy Tribal Communities: A Comprehensive Commentary on Initiatives in India

    by Abhishek Joshi, Juhi M Raut, Abhay Mudey

    Background:Tribal people also called as Indigenous people have diverse languages, cultures, traditional practices or rituals, and customs that distinguish them from the rest of the civic world. Although there are around 104 million tribal people in India they have remained socio-demographically and geographically distant and suffer from various health ailments from communicable diseases like Malaria Tuberculosis and malnutrition to increasing burden of Hypertension and Diabetes. The various health parameters and indicators remain below the National average. The detailed report of Expert committee on tribal health has led the way for various Government ministries and departments to work on addressing the disparity in Tribal health. Aim & Objectives: To summarize and collate all the existing measures for improving tribal health parameters Methodology: We included all the National and International policies and programs along with some examples from Non Government sectors and recent updates. Results: This article summarizes all the initiatives and efforts being undertaken in India by all the stakeholders along with updates on some recent initiatives to understand the holistic efforts towards achieving Holistic Tribal development and how medical colleges can complement these efforts. Conclusion: We collated the overall evidence for creating a comprehensive commentary on Tribal Health initiatives.

  • Open Access

    Pradhan Mantri Janjati Adivasi Nyaya Maha Abhiyan (PM JANMAN): An Endeavor to reach the unreached for improving Healthcare of Tribals in India

    by Abhishek Upendra Joshi, Juhi Mangesh Raut

    One hundred and four Million tribal people live in India, which accounts for 8.6% of the country’s population. The Union Cabinet on 15th November 2023 approved the Pradhan Mantri Janjati Adivasi Nyaya Maha Abhiyan (PM-JANMAN) aiming to reach out to over twenty-two thousand particularly vulnerable Tribal groups (PVTG) tribal habitats over two hundred districts in India. It focuses on the key elements of improving housing and lifestyle, education status, roads and connectivity, livelihood, and the healthcare sector. As per the report of the Expert Committee on Tribal Health, the tribal population in the country faces a triple burden of diseases, some of which are indirectly addressed in this initiative. Other major concerns like alcohol addiction and animal and snake bites have been left out, which could have gone a long way in mitigating these concerns among the tribal population. This initiative if implemented properly will revolutionize the health situation in the tribal communities across the country.


  • Open Access

    Strengthening blood donation practices in low- and middle-income nations

    by Saurabh Shrivastava, Prateek Shrivastava, Abhishek Joshi

    On a global scale, there is a pressing and continuous need for a diverse range of blood and its products to effectively respond to health challenges. As per the global mandate, the provision of safe and adequate blood has been acknowledged as an integral part of every nation’s healthcare policy. Nevertheless, as evident by the global scenario, we are falling short in the majority of healthcare facilities across low- and middle-income nations. Considering the present scenario, there is an immense need to plan and implement specific measures that can improve blood donation practices. The organization of blood donation drives in low- and middle-income nations might encounter a wide range of challenges relevant to all the involved stakeholders. In conclusion, blood donation has universal importance as it can save the lives of people who are in need. This calls for the indispensable need to identify the existing challenges and address them through a multifaceted approach, which essentially includes the involvement of external agencies and active community engagement for sustainable improvements.


  • Open Access

    Unnat Bharat Abhiyan: An Opportunity to participate in a National Program to Implement & Complement Family Adoption Program for Holistic Rural development

    by Juhi M Raut, Abhishek U Joshi

    Medical education in India is predominantly based on Theoretical and bedside teaching. A significant reorientation is needed in medical education, to allow students to understand the grass root level social health dynamics. National Medical commission introduced Family Adoption program as a modality to address this issue to be implemented by all medical colleges for all students admitted from academic year 2022 onwards. The Unnat Bharat Abhiyan (UBA) is a flagship national program of Government of India for holistic rural development by engaging and enabling higher educational institutions to utilize their expertise for accelerating sustainable growth and development of rural India. The Medical Universities/colleges can participate in Unnat Bharat Abhiyan and utilize its platform for implementation of statutory Family adoption program. We developed a Model where in Health sciences Universities/colleges can leverage their expertise in Health care for benefit of adopted villages and Communities by nurturing their health based on our experience of implementing both Unnat Bharat Abhiyan & Family Adoption Program. We propose various measures in which Health sciences Universities/colleges can implement both programs in sync to complement each other towards common goal of welfare of adopted villages. We believe our model is feasible and can address complementary requirements of Unnat Bharat Abhiyan and Family adoption program and benefit all the stakeholders involved.


  • Open Access

    Assessment of the elderly population’s health status as part of the clinical preventive services program

    by Kshatrapal Prajapati, Vijay Prasad Sangishetti, Abhishek Joshi, Abhay Mudey

    Background: Human resources are regarded as a country’s most valuable asset, and they play a critical role in economic development and growth. According to national policy, the elderly population is defined as 60 and up. Because of the rising demand for financial and social support due to health and related difficulties, the government is under pressure to adopt social policies for the elderly. Clinical preventive care can assist reduce the risks and expenses of chronic illness treatment and can prevent or delay disease onset. Method: The aged population of either sex who visit a rural health geriatric centre’s Outpatient department served as the study participants. Data were collected using a self-designed, pre-structured, and pre-validated questionnaire. The information was gathered in the form of a socio-demographic profile, which included all the necessary information, such as socioeconomic status, Body mass index (BMI), and personal habits. Visual examination, hearing, anaemia, musculoskeletal discomfort, diabetes mellitus, dermatological, hypertension, and female patients’ reproductive disorders were all included in the clinical examination. Result: A maximum of 263 (65.75%) of the subjects were in the age group of 60–69 years, 29.25% were labourers, and 38% were in modified BG Prasad class (III) of socioeconomic classification, 184 (46%) people had a BMI of 25–29.99 kg/m2. A total of 102 study participants (25.5%) had a chronic illness. 27.5% of the participants had hypertension, 11.8% had diabetes and coronary heart disease, 20.6% had hypertension and diabetes, and 10.8% had previously suffered from tuberculosis (TB). Hearing loss is a common complaint, and 5.5% reported issues with the genitourinary system, with nocturia accounting for 40.9%. Conclusion: The study participants, who were between the ages of 60 and 69, experienced a variety of chronic illnesses. The majority of the people in the study had hypertension, diabetes, heart disease, hypertension, diabetes, and a TB history.


  • Role of Tocilizumab in Fighting COVID 19

    by Anuttam Arijit Pani, Abhishek Joshi

    Background: Tocilizumab is the repurposed drug used in the severely ill COVID-19 patients. A lot of traction has gain over the drug but more studies are awaited to ensure the efficacy of the drug with proper backing from empirical data. Tocilizumab, a drug which is used in treatment of rheumatoid arthritis suddenly came into limelight when it got listed as drugs used for the treatment of COVID-19 patients. As earlier discussed, many existing drugs which were already in use for treating other ailments were being tested if they are suitable to treat COVID-19 disease. Tocilizumab have the anti-inflammatory properties which were in particular were useful in COVID-19 which creates an inflammation all across the organs. Summary: COVID-19 is the novel disease outbreak later progressed into deadly pandemic has presented the huge challenge to contain it clinically as no drug was available prior the outbreak of the disease. Vast amount of drugs can be used to at least suppress the viral spread which was found to be true. Although it was not hundred percent foolproof but it was an emergency situation and various drugs were used according to local ground conditions and patients response to the drug along with age and severity of the illness. Tocilizumab was one such drug which was repurposed for the treatment of COVID-19 patients. Many drugs such as Hydroxycholoroquine (HCQ), Tocilizumab were repurposed from their existing use. Tocilizumab is currently used in the treatment of rheumatoid arthritis. Various studies have shown the efficacy of the drug among the severely ill COVID-19 patients which ranges up to 66 percent. In certain cases worsening of the existing medical condition has been observed. Conclusion: Vaccine nationalism must be set aside and low and middle income countries where most of the population of the world resides, should be vaccinated as even one case can culminate into another disaster as was seen during highly contagious COVID-19. More empirical data is needed from across the globe to ensure the assessment of the efficacy of the drug. Also certain cases of shortage of the said drug for non-COVID-19 purpose also looked into seriously has it can create a parallel disaster.